3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Myelodysplastic Syndromes
2
Prostatic Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Erectile Dysfunction
1
Bronchiolitis Obliterans Syndrome
1
Interventions
Tadalafil
2
udenafil
1
mirabegron
1
bicalutamide
1
alpha-Tocopherol
1
Vitamin E
1
Tamoxifen
1
Sildenafil Citrate
1
Pentoxifylline
1
Long-Term Synaptic Depression
1
GPI 1485
1
Erythropoietin
1
Dutasteride
1
Atorvastatin
1
Arginine
1
ArginMax
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Erectile Dysfunction
×
Erythropoietin
×
Clear all
NCT00737893
2021-04-08
ERECT
Johns Hopkins University
Phase 2
Completed
56 enrolled
27 charts